GB9721437D0 - Heteroaromatic compounds and their use in medicine - Google Patents

Heteroaromatic compounds and their use in medicine

Info

Publication number
GB9721437D0
GB9721437D0 GBGB9721437.3A GB9721437A GB9721437D0 GB 9721437 D0 GB9721437 D0 GB 9721437D0 GB 9721437 A GB9721437 A GB 9721437A GB 9721437 D0 GB9721437 D0 GB 9721437D0
Authority
GB
United Kingdom
Prior art keywords
medicine
heteroaromatic compounds
heteroaromatic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9721437.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9721437.3A priority Critical patent/GB9721437D0/en
Publication of GB9721437D0 publication Critical patent/GB9721437D0/en
Priority to MA25280A priority patent/MA26550A1/en
Priority to PE1998000949A priority patent/PE120199A1/en
Priority to ARP980105023A priority patent/AR017311A1/en
Priority to PCT/EP1998/006357 priority patent/WO1999021859A1/en
Priority to AU11510/99A priority patent/AU1151099A/en
Priority to ZA9809249A priority patent/ZA989249B/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
GBGB9721437.3A 1997-10-10 1997-10-10 Heteroaromatic compounds and their use in medicine Ceased GB9721437D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9721437.3A GB9721437D0 (en) 1997-10-10 1997-10-10 Heteroaromatic compounds and their use in medicine
MA25280A MA26550A1 (en) 1997-10-10 1998-10-06 HETEROMATIC COMPOUNDS AND THEIR USES IN MEDICINE
PE1998000949A PE120199A1 (en) 1997-10-10 1998-10-07 HETEROAROMATIC COMPOUNDS AND THEIR USE IN MEDICINE
ARP980105023A AR017311A1 (en) 1997-10-10 1998-10-08 HETEROAROMATIC COMPOUNDS, PROCEDURE FOR THEIR PREPARATION, ITS USE FOR THE PREPARATION OF MEDICINES
PCT/EP1998/006357 WO1999021859A1 (en) 1997-10-10 1998-10-08 Azaoxindole derivatives
AU11510/99A AU1151099A (en) 1997-10-10 1998-10-08 Azaoxindole derivatives
ZA9809249A ZA989249B (en) 1997-10-10 1998-10-09 Heteroaromatic compounds and their use in medicine.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721437.3A GB9721437D0 (en) 1997-10-10 1997-10-10 Heteroaromatic compounds and their use in medicine

Publications (1)

Publication Number Publication Date
GB9721437D0 true GB9721437D0 (en) 1997-12-10

Family

ID=10820303

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9721437.3A Ceased GB9721437D0 (en) 1997-10-10 1997-10-10 Heteroaromatic compounds and their use in medicine

Country Status (7)

Country Link
AR (1) AR017311A1 (en)
AU (1) AU1151099A (en)
GB (1) GB9721437D0 (en)
MA (1) MA26550A1 (en)
PE (1) PE120199A1 (en)
WO (1) WO1999021859A1 (en)
ZA (1) ZA989249B (en)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69838172T2 (en) 1997-08-22 2008-04-10 Astrazeneca Ab OXINDOLYLCHINAZOLE DERIVATIVES AS ANGIOGENESEHEMMER
HU230000B1 (en) 1999-02-10 2015-04-28 Astrazeneca Ab Intermediates for the preparation of angiogenesis inhibitory quinazoline derivatives
US20030143676A1 (en) * 1999-03-25 2003-07-31 Genesis Research And Development Corporation Limited Fibroblast growth factor receptors and methods for their use
US7083791B2 (en) 1999-03-25 2006-08-01 Genesis Research & Development Corporation Limited Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
GB9918057D0 (en) * 1999-07-30 1999-10-06 Univ Bristol Therapeutic agents
EP1088821A1 (en) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonamide derivatives
SE9904177D0 (en) * 1999-11-18 1999-11-18 Astra Ab Novel compounds
EP1244672B1 (en) * 1999-12-21 2005-07-20 Sugen, Inc. 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
EP1110957A1 (en) * 1999-12-24 2001-06-27 Applied Research Systems ARS Holding N.V. Benzazole derivatives and their use as JNK modulators
US6323029B1 (en) 2000-01-19 2001-11-27 Isis Pharmaceuticals, Inc. Antisense modulation of glycogen synthase kinase 3 beta expression
US6316259B1 (en) 2000-01-21 2001-11-13 Isis Pharmaceuticals, Inc. Antisense inhibition of glycogen synthase kinase 3 alpha expression
WO2001056557A2 (en) * 2000-02-05 2001-08-09 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of erk
FR2804959B1 (en) * 2000-02-15 2006-04-28 Centre Nat Rech Scient USE OF PAULLON DERIVATIVES FOR THE MANUFACTURE OF MEDICAMENTS
US6465507B2 (en) 2000-02-28 2002-10-15 Sugen, Inc. 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
AU2001276521B2 (en) 2000-08-09 2006-05-25 Astrazeneca Ab Cinnoline compounds
CA2415469A1 (en) 2000-08-09 2002-02-14 Astrazeneca Ab Quinoline derivatives having vegf inhibiting activity
JP2004518662A (en) * 2000-12-19 2004-06-24 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー Pyrazolo [3,4-C] pyridines as GSK-3 inhibitors
US6706724B2 (en) 2000-12-21 2004-03-16 Nitromed, Inc. Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
SE0101230L (en) * 2001-04-06 2002-10-07 Innoventus Project Ab New use of a tyrosine kinase inhibitor
GB0108770D0 (en) 2001-04-06 2001-05-30 Eisai London Res Lab Ltd Inhibitors
US7390808B2 (en) * 2001-04-30 2008-06-24 Vertex Pharmaceuticals Incorporated Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes
EP1401415B1 (en) 2001-06-29 2006-06-21 AB Science Use of n-phenyl-2-pyrimidine-amine derivatives for treating inflammatory diseases
WO2003002109A2 (en) * 2001-06-29 2003-01-09 Ab Science Use of tyrosine kinase inhibitors for treating autoimmune diseases
CA2452366A1 (en) * 2001-06-29 2003-01-16 Ab Science Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
ATE343415T1 (en) 2001-06-29 2006-11-15 Ab Science THE USE OF C-KIT INHIBITORS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
EP1434991B1 (en) 2001-06-29 2007-10-17 AB Science New potent, selective and non toxic c-kit inhibitors
WO2003002106A2 (en) * 2001-06-29 2003-01-09 Ab Science Use of tyrosine kinase inhibitions for treating allergic diseases
EP1430053B1 (en) * 2001-09-27 2006-10-25 SmithKline Beecham Corporation AZAOXOINDOLE DERIVATIVES AS Trk PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND CHRONIC PAIN
AU2003202094B2 (en) 2002-02-01 2009-10-08 Astrazeneca Ab Quinazoline compounds
WO2003082868A1 (en) 2002-03-28 2003-10-09 Eisai Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
AU2003214414B2 (en) 2002-03-28 2008-10-09 Eisai R & D Management Co., Ltd. Azaindoles as inhibitors of c-Jun N-terminal kinases
CA2484797A1 (en) * 2002-05-06 2003-11-13 Washington University Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway
GB0305142D0 (en) 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
WO2004078756A2 (en) 2003-03-06 2004-09-16 Eisai Co., Ltd. Jnk inhibitors
WO2004101565A2 (en) 2003-05-16 2004-11-25 Eisai Co., Ltd. Jnk inhibitors
AR045037A1 (en) 2003-07-10 2005-10-12 Aventis Pharma Sa TETRAHIDRO-1H-PIRAZOLO [3,4-C] SUBSTITUTED PYRIDINS, COMPOSITIONS THAT CONTAIN THEM AND ITS USE.
GB0330002D0 (en) 2003-12-24 2004-01-28 Astrazeneca Ab Quinazoline derivatives
GB0402137D0 (en) * 2004-01-30 2004-03-03 Smithkline Beecham Corp Novel compounds
EP2332940B1 (en) * 2004-03-30 2012-10-31 Vertex Pharmaceuticals Incorporated Azaindoles useful as inhibitors of JAK and other protein kinases
CN1953974A (en) * 2004-05-14 2007-04-25 辉瑞产品有限公司 Pyrimidine derivatives for the treatment of abnormal cell growth
WO2005113561A1 (en) * 2004-05-20 2005-12-01 Sugen, Inc. Cyclicsulfonate pyrrole indolinones as kinase inhibitors
GB0423554D0 (en) 2004-10-22 2004-11-24 Cancer Rec Tech Ltd Therapeutic compounds
JP2009503001A (en) * 2005-08-01 2009-01-29 エフ．ホフマン−ラ ロシュ アーゲー Heterocyclic benzylamino derivatives, their production and use as pharmaceuticals
GB0516156D0 (en) 2005-08-05 2005-09-14 Eisai London Res Lab Ltd JNK inhibitors
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009512711A (en) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Regulation of neurogenesis by PDE inhibition
ES2380236T3 (en) 2005-10-28 2012-05-09 Takeda Pharmaceutical Company Limited Heterocyclic amide compound and use thereof
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
CN102532134A (en) 2006-01-17 2012-07-04 沃泰克斯药物股份有限公司 Azaindoles useful as inhibitors of janus kinases
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2013207B1 (en) 2006-04-26 2012-04-25 Cancer Research Technology Limited Imidazo[4,5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8247421B2 (en) 2006-12-21 2012-08-21 Vertex Pharmaceuticals Incorporated 5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors
KR101665143B1 (en) 2007-12-19 2016-10-11 캔써 리서치 테크놀로지 리미티드 Pyrido[2,3-b]pyrazine-8-substituted compounds and their use
GB0807609D0 (en) 2008-04-25 2008-06-04 Cancer Rec Tech Ltd Therapeutic compounds and their use
WO2010068483A2 (en) 2008-11-25 2010-06-17 University Of Rochester Mlk inhibitors and methods of use
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
TWI574963B (en) 2009-06-17 2017-03-21 維泰克斯製藥公司 Inhibitors of influenza viruses replication
CN102906090B (en) 2010-02-01 2015-06-24 癌症研究技术有限公司 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
US8846909B2 (en) 2010-05-24 2014-09-30 University Of Rochester Bicyclic heteroaryl kinase inhibitors and methods of use
RU2013132681A (en) 2010-12-16 2015-01-27 Вертекс Фармасьютикалз Инкорпорейтед INFLUENZA VIRUS REPLICATION INHIBITORS
CN102115469A (en) * 2011-03-21 2011-07-06 浙江大学 Preparation method for indoline-2-one derivative and application of same
US8669363B2 (en) 2011-03-24 2014-03-11 Southern Methodist University Quinoxaline compounds and derivatives
US9493452B2 (en) * 2011-03-24 2016-11-15 Southern Methodist University Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors
CA2839937C (en) 2011-07-05 2020-11-03 Vertex Pharmaceuticals Incorporated Processes and intermediates for producing azaindoles
UA118010C2 (en) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед INFLUENCES OF INFLUENZA VIRUS REPLICATION
ES2748873T3 (en) 2012-01-26 2020-03-18 Angion Biomedica Corp Antifibrotic compounds and uses thereof
WO2013142831A1 (en) 2012-03-23 2013-09-26 Southern Methodist University Methods of making and using thioxothiazolidine and rhodanine derivatives as hiv-1 and jsp-1 inhibitors
WO2014085795A1 (en) 2012-11-30 2014-06-05 University Of Rochester Mixed lineage kinase inhibitors for hiv/aids therapies
ES2741444T3 (en) 2013-11-13 2020-02-11 Vertex Pharma Inhibitors of influenza virus replication
SI3421468T1 (en) 2013-11-13 2021-03-31 Vertex Pharmaceuticals Incorporated Methods of preparing inhibitors of influenza viruses replication
GB201320732D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Methods of chemical synthesis
GB201320729D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Therapeutic compounds and their use
CN104447733B (en) * 2015-01-05 2016-08-17 中国药科大学 1-benzyl-2-pyrrolinone-4-amides compound and preparation method and application
CN104876928B (en) * 2015-05-07 2016-09-14 浙江司太立制药股份有限公司 7-azaindole quinoline-2-ketone compounds and preparation method thereof
WO2016183116A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Methods of preparing inhibitors of influenza viruses replication
MA42422A (en) 2015-05-13 2018-05-23 Vertex Pharma INHIBITORS OF INFLUENZA VIRUS REPLICATION
NZ742228A (en) * 2015-11-12 2019-09-27 Lg Chemical Ltd Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
SG11201810704WA (en) 2016-05-31 2018-12-28 Taiho Pharmaceutical Co Ltd Sulfonamide compound or salt thereof
US10889555B2 (en) 2016-05-31 2021-01-12 Taiho Pharmaceutical Co., Ltd. Sulfonamide compound or salt thereof
CN106432228A (en) * 2016-09-06 2017-02-22 浙江司太立制药股份有限公司 4-oximido-1-piperidyl fragment containing 7-azaindolin-2-one compound and preparation method therefor
CN106397436A (en) * 2016-09-06 2017-02-15 浙江司太立制药股份有限公司 5-bromo-7-azaindoline-2-one compounds and preparation method thereof
CA3128468A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423997D0 (en) * 1994-11-28 1995-01-11 Erba Carlo Spa Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation

Also Published As

Publication number Publication date
PE120199A1 (en) 1999-12-15
MA26550A1 (en) 2004-12-20
WO1999021859A1 (en) 1999-05-06
AU1151099A (en) 1999-05-17
AR017311A1 (en) 2001-09-05
ZA989249B (en) 2000-04-10

Similar Documents

Publication Publication Date Title
GB9721437D0 (en) Heteroaromatic compounds and their use in medicine
AU3482495A (en) Substituted heteroaromatic compounds and their use in medicine
IL126638A0 (en) Substituted isoquinoline-3-carboxamides their preparation and their use as pharmaceuticals
EP1032377A4 (en) Substituted 2-aminoacetamides and the use thereof
HRP960365B1 (en) New medicaments and the use thereof
ZA982478B (en) Compounds their use and preparation
AP9801175A0 (en) Quinoline and quinoline compounds useful in therapy
ZA9811086B (en) Delivery devices and their use
HUP0000719A3 (en) Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
GB9702354D0 (en) Compounds and their use
CZ2000522A3 (en) Pharmaceutical preparation based on piperidinalkanol antihistaminic and use thereof
PL347542A1 (en) Therapeutic product and its use
IL130348A0 (en) Imidazopyridazines and medicaments containing the same
ZA983740B (en) Novel amidine derivatives and their use in therapy
IL123535A0 (en) Benzoxazindione derivatives and their use
AU8727498A (en) Substituted triazine compounds and their use in medicine
ZA986047B (en) 6-pyrrolidin-2-ylpyrindines their preparation and their therapeutic application
ZA981782B (en) The use of levobupivacaine in combination with other drugs
GB9616504D0 (en) Therapeutic product and its use
GB9704350D0 (en) Compounds and their therapeutic use
GB9715323D0 (en) Piperidinecarboxamides and their use
GB9826537D0 (en) Therapeutic product and its use
GB9826539D0 (en) Therapeutic product and its use
GB9826536D0 (en) Therapeutic product and its use
GB9826535D0 (en) Therapeutic product and its use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)